Abstract
SIGNIFICANCE Oxygen deprivation (hypoxia) is a common feature at sites of inflammation. Immune and all other cells present at the inflamed site have to adapt to these conditions. They do so by stabilization and activation of hypoxia inducible factor subunit α (HIF-1α and HIF-2α, respectively), enabling constant generation of ATP, e.g. glycolytic pathways. RECENT ADVANTAGES During recent years, it has become evident that HIFs play an important role in shaping the inflammatory phenotype of immune cells. They are indispensable for migration, phagocytosis, and the induction of inflammatory cytokines by innate immune cells and thereby enable a crosstalk between innate and adaptive immunity. In short, they ensure the survival and function of immune cells under critical conditions. CRITICAL ISSUES Open questions remain regarding the individual roles of HIF-1 and HIF-2 for the different immune cells. In particular, the loss of both HIF-1 and HIF-2 in myeloid cells led to unexpected and contradictory results in the mouse models. Similarly, the role of HIF-1 in dendritic cell maturation is unclear due to inconsistent results from in vitro experiments. FUTURE DIRECTIONS HIFs are indispensable for immune cell survival and action under inflammatory conditions, but might also trigger their over-activation. With the approval of prolyl hydroxylase inhibitors (PHIs) to stabilize HIF such as roxadustat we need to better understand the extent to which HIF-1 or HIF-2 regulates the adaptation of immune cells and the surrounding tissue to inflammatory hypoxia. Therefore, we urgently need isoform- and cell type-specific modulators of the HIF pathway.

This publication has 102 references indexed in Scilit: